No therapeutic levels exist concerning monitoring. Monitoring of the drug effect and adverse effect profile will be based on clinical symptoms and data, including abdominal symptoms, nutritional intake, weight, growth (in children), stool character, fecal fat. Glucose monitoring is advised if the patient has hypoglycemia or hyperglycemia risk.